The Filings Report

Cencora, Inc.

CORNYSECIK 1140859Healthcare / Healthcare Providers & Servicesfiscal year ends September73 quarters since 2008

Revenue, Q3 FY2026
$84.8B
+5.1% on Q3 FY2025
Net income
$764M
+11.1% on Q3 FY2025
Free cash flow
$2.4B
+3382.5% on Q3 FY2025
Diluted EPS
$3.94
+11.9% on Q3 FY2025
Revenue, TTM
$332.8B
trailing four quarters
Net margin, TTM
0.8%
net income $2.6B
Free cash flow, TTM
$4.1B
$4.8B less $761M capex
Cash and equivalents
$2.8B
long-term debt $11.4B, Jun 30, 2026
Shares, 12-month change
−1.6%
191M shares, Jun 30, 2026
Buybacks, TTM
—
no yield
Dividends, TTM
$468M
0.7% of market value
Market value
$63.1B
at the close, buybacks

Latest quarter Q3 FY2026, filed August 5, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.

In Q3 FY2026, the quarter ended June 30, 2026, Cencora, Inc. reported revenue of $84.8B, +5.1% on Q3 FY2025, and net income of $764M (+11.1%). Operating margin was 1.3%. Free cash flow, operating cash flow less capital expenditures, was $2.4B ($2.7B less $226M). Diluted earnings per share were $3.94.

The last 16 quarters

Q4 FY2022 to Q3 FY2026, through the filing of August 5, 2026.

Revenue and net incomeRevenueNet income
−$25B$0$25B$50B$75B$100BQ4'22, Revenue: $61.2BQ4'22, Net income: $295MQ4'22Q1'23, Revenue: $62.8BQ1'23, Net income: $480MQ1'23Q2'23, Revenue: $63.5BQ2'23, Net income: $435MQ2'23Q3'23, Revenue: $66.9BQ3'23, Net income: $480MQ3'23Q4'23, Revenue: $68.9BQ4'23, Net income: $351MQ4'23Q1'24, Revenue: $72.3BQ1'24, Net income: $602MQ1'24Q2'24, Revenue: $68.4BQ2'24, Net income: $421MQ2'24Q3'24, Revenue: $74.2BQ3'24, Net income: $483MQ3'24Q4'24, Revenue: $79.1BQ4'24, Net income: $3MQ4'24Q1'25, Revenue: $81.5BQ1'25, Net income: $489MQ1'25Q2'25, Revenue: $75.5BQ2'25, Net income: $718MQ2'25Q3'25, Revenue: $80.7BQ3'25, Net income: $687MQ3'25Q4'25, Revenue: $83.7BQ4'25, Net income: −$340MQ4'25Q1'26, Revenue: $85.9BQ1'26, Net income: $560MQ1'26Q2'26, Revenue: $78.4BQ2'26, Net income: $1.6BQ2'26Q3'26, Revenue: $84.8BQ3'26, Net income: $764MQ3'26−$25B$0$25B$50B$75B$100BQ4'22, Revenue: $61.2BQ4'22, Net income: $295MQ1'23, Revenue: $62.8BQ1'23, Net income: $480MQ1'23Q2'23, Revenue: $63.5BQ2'23, Net income: $435MQ3'23, Revenue: $66.9BQ3'23, Net income: $480MQ3'23Q4'23, Revenue: $68.9BQ4'23, Net income: $351MQ1'24, Revenue: $72.3BQ1'24, Net income: $602MQ1'24Q2'24, Revenue: $68.4BQ2'24, Net income: $421MQ3'24, Revenue: $74.2BQ3'24, Net income: $483MQ3'24Q4'24, Revenue: $79.1BQ4'24, Net income: $3MQ1'25, Revenue: $81.5BQ1'25, Net income: $489MQ1'25Q2'25, Revenue: $75.5BQ2'25, Net income: $718MQ3'25, Revenue: $80.7BQ3'25, Net income: $687MQ3'25Q4'25, Revenue: $83.7BQ4'25, Net income: −$340MQ1'26, Revenue: $85.9BQ1'26, Net income: $560MQ1'26Q2'26, Revenue: $78.4BQ2'26, Net income: $1.6BQ3'26, Revenue: $84.8BQ3'26, Net income: $764MQ3'26

Net income losses drawn in red.

Free cash flow
−$4B−$2B$0$2B$4BQ4'22, Free cash flow: $991MQ4'22Q1'23, Free cash flow: $634MQ1'23Q2'23, Free cash flow: $527MQ2'23Q3'23, Free cash flow: $641MQ3'23Q4'23, Free cash flow: $1.7BQ4'23Q1'24, Free cash flow: $811MQ1'24Q2'24, Free cash flow: −$991MQ2'24Q3'24, Free cash flow: $2.4BQ3'24Q4'24, Free cash flow: $818MQ4'24Q1'25, Free cash flow: −$2.8BQ1'25Q2'25, Free cash flow: $3.2BQ2'25Q3'25, Free cash flow: −$74MQ3'25Q4'25, Free cash flow: $2.9BQ4'25Q1'26, Free cash flow: −$2.4BQ1'26Q2'26, Free cash flow: $1.2BQ2'26Q3'26, Free cash flow: $2.4BQ3'26−$4B−$2B$0$2B$4BQ4'22, Free cash flow: $991MQ1'23, Free cash flow: $634MQ1'23Q2'23, Free cash flow: $527MQ3'23, Free cash flow: $641MQ3'23Q4'23, Free cash flow: $1.7BQ1'24, Free cash flow: $811MQ1'24Q2'24, Free cash flow: −$991MQ3'24, Free cash flow: $2.4BQ3'24Q4'24, Free cash flow: $818MQ1'25, Free cash flow: −$2.8BQ1'25Q2'25, Free cash flow: $3.2BQ3'25, Free cash flow: −$74MQ3'25Q4'25, Free cash flow: $2.9BQ1'26, Free cash flow: −$2.4BQ1'26Q2'26, Free cash flow: $1.2BQ3'26, Free cash flow: $2.4BQ3'26

Operating cash flow less capital expenditures; negative quarters in red.

Cash and equivalents against long-term debtCash and equivalentsLong-term debt
$0$5B$10B$15BQ4'22, Cash and equivalents: $3.4BQ4'22, Long-term debt: $4.6BQ4'22Q1'23, Cash and equivalents: $1.7BQ1'23, Long-term debt: $4.7BQ1'23Q2'23, Cash and equivalents: $1.5BQ2'23, Long-term debt: $4.7BQ2'23Q3'23, Cash and equivalents: $1.4BQ3'23, Long-term debt: $4.2BQ3'23Q4'23, Cash and equivalents: $2.6BQ4'23, Long-term debt: $4.1BQ4'23Q1'24, Cash and equivalents: $2.9BQ1'24, Long-term debt: $4.2BQ1'24Q2'24, Cash and equivalents: $2.1BQ2'24, Long-term debt: $4.2BQ2'24Q3'24, Cash and equivalents: $3.3BQ3'24, Long-term debt: $4.2BQ3'24Q4'24, Cash and equivalents: $3.1BQ4'24, Long-term debt: $3.8BQ4'24Q1'25, Cash and equivalents: $3.2BQ1'25, Long-term debt: $5.9BQ1'25Q2'25, Cash and equivalents: $2.0BQ2'25, Long-term debt: $7.1BQ2'25Q3'25, Cash and equivalents: $2.2BQ3'25, Long-term debt: $8.0BQ3'25Q4'25, Cash and equivalents: $4.4BQ4'25, Long-term debt: $7.5BQ4'25Q1'26, Cash and equivalents: $1.8BQ1'26, Long-term debt: $7.6BQ1'26Q2'26, Cash and equivalents: $2.2BQ2'26, Long-term debt: $12.2BQ2'26Q3'26, Cash and equivalents: $2.8BQ3'26, Long-term debt: $11.4BQ3'26$0$5B$10B$15BQ4'22, Cash and equivalents: $3.4BQ4'22, Long-term debt: $4.6BQ1'23, Cash and equivalents: $1.7BQ1'23, Long-term debt: $4.7BQ1'23Q2'23, Cash and equivalents: $1.5BQ2'23, Long-term debt: $4.7BQ3'23, Cash and equivalents: $1.4BQ3'23, Long-term debt: $4.2BQ3'23Q4'23, Cash and equivalents: $2.6BQ4'23, Long-term debt: $4.1BQ1'24, Cash and equivalents: $2.9BQ1'24, Long-term debt: $4.2BQ1'24Q2'24, Cash and equivalents: $2.1BQ2'24, Long-term debt: $4.2BQ3'24, Cash and equivalents: $3.3BQ3'24, Long-term debt: $4.2BQ3'24Q4'24, Cash and equivalents: $3.1BQ4'24, Long-term debt: $3.8BQ1'25, Cash and equivalents: $3.2BQ1'25, Long-term debt: $5.9BQ1'25Q2'25, Cash and equivalents: $2.0BQ2'25, Long-term debt: $7.1BQ3'25, Cash and equivalents: $2.2BQ3'25, Long-term debt: $8.0BQ3'25Q4'25, Cash and equivalents: $4.4BQ4'25, Long-term debt: $7.5BQ1'26, Cash and equivalents: $1.8BQ1'26, Long-term debt: $7.6BQ1'26Q2'26, Cash and equivalents: $2.2BQ2'26, Long-term debt: $12.2BQ3'26, Cash and equivalents: $2.8BQ3'26, Long-term debt: $11.4BQ3'26

Positions at each quarter end, as filed; short-term investments are not included.

Income statement

Last eight quarters, newest first, through Q3 FY2026 filed August 5, 2026.

Cencora, Inc. income statement, quarterly
Millions of dollarsQ3 FY2026ended Jun 30, 2026filed Aug 5, 2026Q2 FY2026ended Mar 31, 2026filed May 6, 2026Q1 FY2026ended Dec 31, 2025filed Feb 4, 2026Q4 FY2025ended Sep 30, 2025filed Nov 25, 2025Q3 FY2025ended Jun 30, 2025filed Aug 6, 2025Q2 FY2025ended Mar 31, 2025filed May 7, 2025Q1 FY2025ended Dec 31, 2024filed Feb 5, 2025Q4 FY2024ended Sep 30, 2024filed Nov 26, 2024YoYQ3 FY2026vs Q3 FY2025
Revenue84,75578,35685,93283,72980,66475,45481,48779,050+5.1%
Cost of revenue81,14874,76882,86080,77577,75672,39478,92976,558+4.4%
Gross profit3,6073,5883,0722,9542,9073,0602,5582,492+24.1%
Research and development—————————
Selling, general and administrative2,1321,9781,7951,7491,6731,6001,4721,490+27.5%
Operating income1,1201,143760198681,036706127+29.1%
Other income (expense)171,08621(128)110(4)(58)20−84.7%
Pretax income9962,089709(187)896929620125+11.2%
Income tax220459143146207211127118+6.4%
Net income7641,641560(340)6877184893+11.1%
Diluted EPS ($)3.948.402.87—3.523.682.50—+11.9%
Diluted shares (millions)194195195—195195195——

Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.

Balance sheet

Last eight quarters, newest first, through Q3 FY2026 filed August 5, 2026.

Cencora, Inc. balance sheet, quarterly
Millions of dollarsQ3 FY2026ended Jun 30, 2026filed Aug 5, 2026Q2 FY2026ended Mar 31, 2026filed May 6, 2026Q1 FY2026ended Dec 31, 2025filed Feb 4, 2026Q4 FY2025ended Sep 30, 2025filed Nov 25, 2025Q3 FY2025ended Jun 30, 2025filed Aug 6, 2025Q2 FY2025ended Mar 31, 2025filed May 7, 2025Q1 FY2025ended Dec 31, 2024filed Feb 5, 2025Q4 FY2024ended Sep 30, 2024filed Nov 26, 2024YoYQ3 FY2026vs Q3 FY2025
Cash and equivalents2,8152,1761,7534,3562,2321,9783,2243,133+26.1%
Short-term investments—————————
Total current assets55,33553,14154,15252,23948,81446,53549,98747,718+13.4%
Total assets83,80681,65278,36176,59073,95771,19469,05467,102+13.3%
Total current liabilities59,19756,13259,13257,82153,95853,32854,50954,277+9.7%
Long-term debt11,44412,1837,5797,5438,0447,0865,9353,812+42.3%
Total liabilities—————————
Stockholders’ equity3,0513,3981,9081,5081,9801,013227646+54.1%
Shares outstanding (millions)191195195194194194194193—

Positions at each period end. Nothing on this statement is derived. Long-term debt is the filed noncurrent line only; no total-debt composite is constructed across filers. Italic figures are derived.

Cash flow statement

Last eight quarters, newest first, through Q3 FY2026 filed August 5, 2026.

Cencora, Inc. cash flow statement, quarterly
Millions of dollarsQ3 FY2026ended Jun 30, 2026filed Aug 5, 2026Q2 FY2026ended Mar 31, 2026filed May 6, 2026Q1 FY2026ended Dec 31, 2025filed Feb 4, 2026Q4 FY2025ended Sep 30, 2025filed Nov 25, 2025Q3 FY2025ended Jun 30, 2025filed Aug 6, 2025Q2 FY2025ended Mar 31, 2025filed May 7, 2025Q1 FY2025ended Dec 31, 2024filed Feb 5, 2025Q4 FY2024ended Sep 30, 2024filed Nov 26, 2024YoYQ3 FY2026vs Q3 FY2025
Operating cash flow2,6541,339(2,305)3,1331093,351(2,719)1,000+2329.4%
Capital expenditures226166119250183129106182+23.4%
Free cash flow (CFO − capex)2,4281,173(2,425)2,884(74)3,222(2,825)818+3382.5%
Depreciation and amortization269249260259254260278—+6.1%
Share repurchases———0050385505—
Dividends paid117117127108107111111101+8.5%

10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.

Annual statements

Every fiscal year filed, newest first, through FY2025 filed November 25, 2025.

Income statement

Cencora, Inc. income statement, annual
Millions of dollarsFY2025ended Sep 30, 2025filed Nov 25, 2025FY2024ended Sep 30, 2024filed Nov 26, 2024FY2023ended Sep 30, 2023filed Nov 21, 2023FY2022ended Sep 30, 2022filed Nov 22, 2022FY2021ended Sep 30, 2021filed Nov 23, 2021FY2020ended Sep 30, 2020filed Nov 19, 2020FY2019ended Sep 30, 2019filed Nov 19, 2019FY2018ended Sep 30, 2018filed Nov 20, 2018FY2017ended Sep 30, 2017filed Nov 21, 2017FY2016ended Sep 30, 2016filed Nov 22, 2016FY2015ended Sep 30, 2015filed Nov 24, 2015FY2014ended Sep 30, 2014filed Nov 25, 2014FY2013ended Sep 30, 2013filed Nov 26, 2013FY2012ended Sep 30, 2012filed Nov 27, 2012FY2011ended Sep 30, 2011filed Nov 22, 2011FY2010ended Sep 30, 2010filed Nov 23, 2010FY2009ended Sep 30, 2009filed Nov 25, 2009FY2008ended Sep 30, 2008filed Aug 6, 2009FY2007ended Sep 30, 2007filed Aug 6, 2009
Revenue321,333293,959262,173238,587213,989189,894179,589167,940153,144146,850135,962119,56987,95978,08178,69677,77671,76070,19065,672
Cost of revenue309,854284,049253,214230,291207,046184,702174,451163,327148,598142,577—————————
Gross profit11,4799,9108,9598,2966,9435,1925,1384,6124,5464,2733,5292,9822,5082,6352,4592,3252,1002,0472,219
Research and development———————————————————
Selling, general and administrative6,4945,6615,3104,8493,5942,7672,6642,4602,1292,0911,9081,5811,3341,1531,1381,1511,1201,1191,340
Operating income2,6292,1752,3412,3662,354(5,135)1,1121,4441,0601,5264227828981,3041,1901,092884828789
Other income (expense)(79)(14)492742213(25)35(14)4065(3)(1)(2)(3)
Pretax income2,2582,0042,1612,1832,222(5,294)9671,1779181,3912696708241,2171,1181,016824761753
Income tax691485428517677(1,894)113(438)553(37)407388331456420386312292279
Net income1,5541,5091,7451,6991,540(3,409)8551,6583641,428(138)274434719707637503251469
Diluted EPS ($)7.967.538.538.047.39(16.65)4.047.531.646.32(0.63)1.161.842.802.542.221.660.771.25
Diluted shares (millions)195200205211208205212220222226218235235*257278287303325376

Balance sheet

Cencora, Inc. balance sheet, annual
Millions of dollarsFY2025ended Sep 30, 2025filed Nov 25, 2025FY2024ended Sep 30, 2024filed Nov 26, 2024FY2023ended Sep 30, 2023filed Nov 21, 2023FY2022ended Sep 30, 2022filed Nov 22, 2022FY2021ended Sep 30, 2021filed Nov 23, 2021FY2020ended Sep 30, 2020filed Nov 19, 2020FY2019ended Sep 30, 2019filed Nov 19, 2019FY2018ended Sep 30, 2018filed Nov 20, 2018FY2017ended Sep 30, 2017filed Nov 21, 2017FY2016ended Sep 30, 2016filed Nov 22, 2016FY2015ended Sep 30, 2015filed Nov 24, 2015FY2014ended Sep 30, 2014filed Nov 25, 2014FY2013ended Sep 30, 2013filed Nov 26, 2013FY2012ended Sep 30, 2012filed Nov 27, 2012FY2011ended Sep 30, 2011filed Nov 22, 2011FY2010ended Sep 30, 2010filed Nov 23, 2010FY2009ended Sep 30, 2009filed Nov 25, 2009FY2008ended Sep 30, 2008filed Aug 6, 2009FY2007ended Sep 30, 2007filed Aug 6, 2009
Cash and equivalents4,3563,1332,5923,3882,5474,5983,3742,4932,4352,7422,1671,8091,2311,0671,8261,6581,009878640
Short-term investments———————————————————
Total current assets52,23947,71842,79939,59038,80333,05628,13225,89424,30322,85220,33416,80014,39411,05811,37510,7489,9548,670—
Total assets76,59067,10262,55956,56157,33844,27539,17237,67035,31633,63827,96321,53218,91915,44214,98314,43513,57312,218—
Total current liabilities57,82154,27748,83143,47841,35933,85329,58127,87026,81825,28021,57817,25014,87111,26610,8759,9069,4808,168—
Long-term debt7,5433,8124,1464,6326,3843,6184,0344,1593,4303,5763,4931,9961,3971,3969731,3431,1771,187—
Total liabilities———————————————————
Stockholders’ equity1,508646522(212)223(1,019)2,8792,9332,0642,1296161,9432,3082,4552,8672,9542,7162,7103,100
Shares outstanding (millions)194193201206208204206212218220206219230235258276288——

Cash flow statement

Cencora, Inc. cash flow statement, annual
Millions of dollarsFY2025ended Sep 30, 2025filed Nov 25, 2025FY2024ended Sep 30, 2024filed Nov 26, 2024FY2023ended Sep 30, 2023filed Nov 21, 2023FY2022ended Sep 30, 2022filed Nov 22, 2022FY2021ended Sep 30, 2021filed Nov 23, 2021FY2020ended Sep 30, 2020filed Nov 19, 2020FY2019ended Sep 30, 2019filed Nov 19, 2019FY2018ended Sep 30, 2018filed Nov 20, 2018FY2017ended Sep 30, 2017filed Nov 21, 2017FY2016ended Sep 30, 2016filed Nov 22, 2016FY2015ended Sep 30, 2015filed Nov 24, 2015FY2014ended Sep 30, 2014filed Nov 25, 2014FY2013ended Sep 30, 2013filed Nov 26, 2013FY2012ended Sep 30, 2012filed Nov 27, 2012FY2011ended Sep 30, 2011filed Nov 22, 2011FY2010ended Sep 30, 2010filed Nov 23, 2010FY2009ended Sep 30, 2009filed Nov 25, 2009FY2008ended Sep 30, 2008filed Aug 6, 2009FY2007ended Sep 30, 2007filed Aug 6, 2009
Operating cash flow3,8753,4853,9112,7032,6672,2072,3441,4111,5043,1783,9221,4657881,3051,1681,1097847371,208
Capital expenditures668487458496438370310336466465232264202133156176146137111
Free cash flow (CFO − capex)3,2072,9983,4532,2072,2281,8372,0341,0751,0382,7143,6911,2005861,1721,0129326386001,097
Depreciation and amortization1,0511,09296469450539146246539836524918916213410184———
Share repurchases4351,4911,181484824206746393302,2661,8597544841,1628414704506801,434
Dividends paid43741639939236734433933332028825421419613311891634937

Insider activity

Form 4 filings by officers, directors and 10% owners, November 1, 2024 to November 1, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.

Bought, three months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, three months
$5M
4 sales by 3 insiders; officers and directors $5M
Bought, twelve months
$2M
3 purchases by 2 insiders; officers and directors $2M
Sold, twelve months
$15M
12 sales by 5 insiders; officers and directors $15M

The last 25 transactions

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Oct 1, 2026Sanchez Robert EDirectoraward275——275Oct 5, 2026
Oct 1, 2026Krikorian LazarusSVP & Chief Accounting Officeropen-market sale10b5-1986$303.18$299K15,183Oct 5, 2026
Sep 16, 2026Greenberg Lon RDirectoropen-market sale1,280$321.30$411K17,128Sep 17, 2026
Sep 1, 2026Krikorian LazarusSVP & Chief Accounting Officeropen-market sale10b5-1985$325.97$321K16,169Sep 2, 2026
Aug 24, 2026Campbell Elizabeth SExecutive Vice Presidentopen-market sale11,300$324.12$4M19,455Aug 25, 2026
Jul 31, 2026Nally Dennis MDirectoraward113$311.34$35K13,188Aug 4, 2026
Jul 31, 2026Cooper EllenDirectoraward97$311.34$30K893Aug 4, 2026
Jul 31, 2026Tyler Lauren MDirectoraward97$311.34$30K4,456Aug 4, 2026
Jun 30, 2026Battaglia SilvanaExecutive Vice Presidentaward58$240.53$14K23,624Jul 7, 2026
Jun 30, 2026Campbell Elizabeth SExecutive Vice Presidentaward50$240.53$12K30,756Jul 7, 2026
Jun 22, 2026Tyler Lauren MDirectoropen-market buy550$270.23$149K4,359Jun 24, 2026
Jun 18, 2026Durcan Dermot MarkDirectoropen-market buy4,000$274.19$1M31,767Jun 22, 2026
May 28, 2026Durcan Dermot MarkDirectoropen-market buy4,000$266.26$1M27,767May 28, 2026
May 1, 2026Tyler Lauren MDirectoraward99$304.00$30K3,809May 5, 2026
May 1, 2026Cooper EllenDirectoraward99$304.00$30K796May 5, 2026
May 1, 2026Nally Dennis MDirectoraward116$304.00$35K13,075May 5, 2026
Mar 11, 2026Battaglia SilvanaExecutive Vice Presidenttax withholding3,673$350.30$1M23,566Mar 13, 2026
Mar 11, 2026Battaglia SilvanaExecutive Vice Presidentoption exercise8,415$0.00—27,239Mar 13, 2026
Mar 11, 2026Campbell Elizabeth SExecutive Vice Presidentoption exercise12,623$0.00—36,548Mar 13, 2026
Mar 11, 2026Campbell Elizabeth SExecutive Vice Presidenttax withholding5,842$350.30$2M30,706Mar 13, 2026
Mar 11, 2026Cleary James FChief Financial Officeroption exercise12,623$0.00—165,766Mar 13, 2026
Mar 11, 2026Cleary James FChief Financial Officertax withholding5,409$350.30$2M160,357Mar 13, 2026
Mar 5, 2026Cooper EllenDirectoraward557$359.28$200K697Mar 9, 2026
Mar 5, 2026Nally Dennis MDirectoraward557$359.28$200K12,959Mar 9, 2026
Mar 5, 2026Tyler Lauren MDirectoraward557$359.28$200K3,710Mar 9, 2026

Full insider history for Cencora, Inc., or insider activity across all companies. A record of filings, not a recommendation.

Sources

Fiscal year ends in month 9; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.

Filer
CENCORA, INC., CIK 1140859 on EDGAR
Extract generated
August 27, 2026
Withheld
1 line-years whose four quarters do not sum to the filed year: revenue FY2011
Repaired
1 quarters where a full-year figure was filed in a quarter slot and the quarter was rebuilt: other income FY2022
XBRL concepts behind each line

Income statement

Revenue: Revenues
Cost of revenue: CostOfGoodsAndServicesSold
Gross profit: GrossProfit
Research and development: not filed
Selling, general and administrative: SellingGeneralAndAdministrativeExpense
Operating income: OperatingIncomeLoss
Other income (expense): NonoperatingIncomeExpense
Pretax income: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest, IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Income tax: IncomeTaxExpenseBenefit
Net income: NetIncomeLoss
Diluted EPS ($): EarningsPerShareDiluted
Diluted shares (millions): WeightedAverageNumberOfDilutedSharesOutstanding

Balance sheet

Cash and equivalents: CashAndCashEquivalentsAtCarryingValue
Short-term investments: not filed
Total current assets: AssetsCurrent
Total assets: Assets
Total current liabilities: LiabilitiesCurrent
Long-term debt: LongTermDebt, LongTermDebtNoncurrent
Total liabilities: not filed
Stockholders’ equity: StockholdersEquity
Shares outstanding (millions): dei:EntityCommonStockSharesOutstanding

Cash flow statement

Operating cash flow: NetCashProvidedByUsedInOperatingActivities
Capital expenditures: PaymentsToAcquirePropertyPlantAndEquipment
Free cash flow (CFO − capex): not filed
Depreciation and amortization: DepreciationDepletionAndAmortization
Share repurchases: PaymentsForRepurchaseOfCommonStock
Dividends paid: PaymentsOfDividendsCommonStock

The data

The statements on this page as files, generated August 27, 2026.

JSON file
/data/financials/COR.json